Resmetirom For MASH: Approved by US FDA, Increase in Partnerships
The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.
Stay updated with breaking news from Deals Database. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.
Article - Global Travel and Tourism Sector Deal Activity Fell by 14.9% YoY in Q1 2024, According to GlobalData - Travel and tourism sector witnessed the announcement of 165 deals globally during the first quarter (Q1) of 2024. This represents a year-on-year (YoY) decline of 14.9% compared to the announcement of 194 deals during the same period last year, according to GlobalData.
Article - Travel and Tourism Sector Deal Activity Down by 22.5% YoY During January-February 2024 - The travel and tourism sector witnessed the announcement of 93 deals globally during the first two months of 2024, an year-on-year (YoY) decline of 22.5% compared to the announcement of 120 deals during the same period in 2023.
Germany VC investment surges despite global downturn but calls for innovation strategy to foster unicorn growth
Global deal activity fell by 34.1% YoY in January 2024